Standard
UCSF Scientists Develop "Smart" Immune Therapy Capable of Targeting Deadly Childhood Brain Cancer
In a significant leap forward for pediatric oncology, researchers at the University of California, San Francisco (UCSF) have unveiled a sophisticated new form of immune cell therapy designed to bypass the traditional pitfalls of cancer treatment. This experimental therapy, known as B-SYNC CAR-T, is engineered to remain dormant while circulating through the body and to…
